Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other neoplasm 1Gastrointestinal 1

Conditions

Breast Neoplasms 16Lung Neoplasms 5Carcinoma, Ovarian Epithelial 5Carcinoma, Non-Small-Cell Lung 5Unspecified Adult Solid Tumor, Protocol Specific 4Squamous Cell Carcinoma of Head and Neck 4Rectal Neoplasms 4Prostatic Neoplasms 4Ovarian Neoplasms 4Head and Neck Neoplasms 4Colorectal Neoplasms 4Colonic Neoplasms 4Carcinoma, Intraductal, Noninfiltrating 4Breast Carcinoma In Situ 4Brain Neoplasms 4Sarcoma 3Liver Neoplasms 3Central Nervous System Neoplasms 3Carcinoma, Hepatocellular 3Salivary Gland Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Precancerous Conditions 2Pancreatic Neoplasms 2Neoplasm Metastasis 2Melanoma 2Lymphoma, Large-Cell, Anaplastic 2Leukemia, Myeloid, Acute 2Leukemia 2Gliosarcoma 2Glioblastoma 2

Interventions

Gemcitabine 94Cisplatin 71Capecitabine 39Oxaliplatin 38durvalumab 29Fluorouracil 27pembrolizumab 26Leucovorin 23S 1 (combination) 19Nivolumab 14Irinotecan 14lenvatinib 13Bevacizumab 11tremelimumab 10130-nm albumin-bound paclitaxel 9apatinib 8Trastuzumab 7Injections 7Immune Checkpoint Inhibitors 7Docetaxel 7Albumin-Bound Paclitaxel 7Paclitaxel 6Drug Therapy 6titanium silicide 5surufatinib 5irinotecan sucrosofate 5gemcitabine-oxaliplatin regimen 5envafolimab 5camrelizumab 5atezolizumab 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Biliary Tract Neoplasms × Mass Spectrometry × Clear all
NCT04445532 2023-07-07

Hepatobiliary Tumors Tissue Samples Acquisition

Peking Union Medical College Hospital

Unknown
450 enrolled
GastrointestinalOther neoplasm

Biliary Tract Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms, Precancerous Conditions, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡